In this custom video series, experts present considerations regarding the appropriate management of patients on antipsychotic therapy and use of VMAT2 inhibitors as therapy for patients who develop tardive dyskinesia.
EP. 1: Case Scenario 1: Patient With Bipolar 1 Disorder Reports New Onset Movements
June 25th 2021In this custom video series, experts share overall impressions of a female patient with bipolar 1 disorder who develops new onset movements suggesting tardive dyskinesia and the rationale for intervening with VMAT2 therapy.
Watch
EP. 2: Case Scenario 2: Patient With Tardive Dyskinesia Prescribed a VMAT2 Inhibitor
June 25th 2021In this custom video series, Leslie L. Citrome, MD, MPH, and Rose Mary Xavier, PhD, MS, RN, PMHNP-BC, review the case of a male patient with schizophrenia who develops symptoms of tardive dyskinesia and comments on the appropriateness for intervening with VMAT2 inhibitor therapy.
Watch
EP. 4: Assessing Severity of Tardive Dyskinesia
June 25th 2021In this custom video series, Leslie L. Citrome, MD, MPH, and Rose Mary Xavier, PhD, MS, RN, PMHNP-BC, reference the Abnormal Involuntary Movement Scale (AIMS) rating scale, used to assess the severity of involuntary movements and help diagnose tardive dyskinesia.
Watch
EP. 5: Managing Patients on Antipsychotic Therapy
June 25th 2021In this custom video series, experts provide insight into strategies that may be helpful to healthcare professionals who manage patients on antipsychotic therapy to best monitor for signs of tardive dyskinesia, with special considerations regarding telepsychiatry.
Watch
EP. 6: Anticholinergic Medications and Impaired Cognition
June 25th 2021In this custom video series, Leslie L. Citrome, MD, MPH, and Rose Mary Xavier, PhD, MS, RN, PMHNP-BC, caution against the use of anticholinergic medications for Parkinson’s disease and comment on the use of alternative therapies for appropriate patients.
Watch
EP. 9: Prevention and Early Detection of Tardive Dyskinesia
June 25th 2021In this custom video series, Rose Mary Xavier, PhD, MS, RN, PMHNP-BC, shares advice that can be helpful to community providers who manage children and adult patients prescribed antipsychotic therapy about screening for involuntary body movements and early signs of tardive dyskinesia.
Watch
EP. 10: Expert Perspectives on Recognition and Management of Tardive Dyskinesia
July 30th 2021Clinical experiences and insights in this Case-Based Psych Perspectives were shared by Leslie L. Citrome, MD, MPH, a psychiatry specialist from Valhalla, New York, and Rose Mary Xavier, PhD, MS, RN, PMHNP-BC, a research scientist and psychiatric nurse practitioner from Chapel Hill, North Carolina. This article provides a summary of key discussion topics from this custom program.
Read More